Package | us.nlm.vsac |
Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1196.491 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.491/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.491 |
Version | 20210909 |
Status | active |
Date | 2021-09-09T01:00:51-04:00 |
Name | MediumDoseICSFormoterolPreparations |
Title | Medium Dose ICS Formoterol Preparations |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with formoterol that are used for medium-dose single maintenance and reliever therapy (SMART) in asthmatic adults and children at least 4 years old.),(Data Element Scope: FHIR MedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes oral ICS-formoterol preparations that might reasonably be used to treat asthmatic children age 4+ years and adults with daily and PRN combination medium-dose ICS-formoterol as per Step 4 in the NHLBI NAEPP 2020 Focused Updates to the Asthma Management Guidelines. The medium-dose range refers to the ICS component as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007). Maintenance ICS ranges are different for age 12+ yrs vs. younger asthmatics, but medium-dose ranges are easily satisfied with the included preparations, which include formoterol in combination with budesonide 160 mcg/actuation (0.16 mg/actuation) and formoterol in combination with mometasone 200 mcg/actuation (0.2 mg/actuation).),(Exclusion Criteria: Excludes withdrawn preparations and retired codes (although they may still be available from pharmacies until supplies are exhausted); excludes low-dose oral ICS-formoterol preparations that are less likely to be used to treat asthmatics age 4+ in the medium-dose ranges as per the NHLBI NAEPP EPR3 Guidelines for the Diagnosis and Management of Asthma (2007).) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
No narrative content found in resource